| Literature DB >> 36230305 |
Yang Jiao1,2,3, Shujie Liu1,2,3, Yanan Zhou1,2,3, Deyu Yang1,2,3, Jilan Li1,2,3, Zhanhong Cui1,2,3.
Abstract
This experiment was conducted to investigate the effect of supplemental concentrate feeding on the pancreatic development of yak calves. Twenty one-month-old yak calves with healthy body condition and similar body weight were selected as experimental animals and randomly divided into two groups, five replicates in each group. The control group yak calves were fed milk replacer and alfalfa hay, the experimental group yak calves were fed milk replacer, alfalfa hay and concentrate. The pre-feeding period of this experiment was thirty days, the trial period was one hundred days. At the end of feeding trail, five yak calves from each group were selected and slaughtered and the pancreas tissues of yak calves were collected and determined. The results showed that: (1) Dry matter and body weight of yak calves in the test group were significantly higher than those of the control group. (2) The apparent nutrient digestibility of crude protein, crude fat, calcium and phosphorus in the test group of yak calves was significantly higher than that of the control group, while the apparent nutrient digestibility of neutral detergent fiber and acid detergent fiber in the test group was significantly lower than that of the control group. (3) Pancreatic weight, organ index, total ratio of exocrine part area and total ratio of endocrine area of yak calves in the test group were significantly higher than those in the control group, while the ratio of exocrine area was significantly lower in the test group than that of the control group. (4) The activities of the main pancreatic digestive enzymes: pancreatic amylase, pancreatic lipase, pancreatic protease and chymotrypsin were significantly higher in the test group than those of the control group, as were the hormonal contents of glucagon, insulin and pancreatic polypeptide. (5) The main differential metabolites of the pancreas in the test group were significantly higher than those of the control group, such as D-proline, hypoxanthine, acetylcysteine, gamma-glutamylcysteine, thiazolidine-4-carboxylic acid, piperidinic acid, ellagic acid, nicotinamide, tropolone, D-serine, ribulose-5-phosphate, (+/-)5(6)-epoxyeicosatrienoic acid(EET), 2-hydroxycinnamic acid, L-phenylalanine, creatinine, tetrahydrocorticosterone, pyridoxamine, xanthine, 5-oxoproline, asparagine, DL-tryptophan, in-dole-3-acrylic acid, thymine, trehalose, docosapentaenoic acid, docosahexaenoic acid, fatty acid esters of hydroxy fatty acids(FAHFA) (18:1/20:3), fatty acid esters of hydroxy fatty acids(FAHFA) (18:2/20:4), adrenic acid and xanthosine. In conclusion, supplemental concentrate feeding promoted the good development of morphological and functional properties of the pancreas in early weaned yak calves to improve the digestion and absorption of feed nutrients, so as to enhance the growth and development quality of early weaned yak calves.Entities:
Keywords: growth performance; metabolomics; pancreas development; supplemental concentrate feeding; yak calves
Year: 2022 PMID: 36230305 PMCID: PMC9558514 DOI: 10.3390/ani12192563
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 3.231
Nutritional components of milk replacer, alfalfa hay and supplementary concentrate (dry matter basis) (Unit: %).
| Items | Milk Replacer Powder | Alfalfa Hay | Concentrates |
|---|---|---|---|
| Crude protein (CP) | 26.24 | 12.50 | 20.00 |
| Ether extract (EE) | 27.90 | 0.90 | 4.70 |
| Neutral detergent fiber (NDF) | - | 56.45 | 10.90 |
| Acid detergent fiber (ADF) | - | 40.40 | 4.10 |
| Calcium (Ca) | 2.50 | 0.98 | 0.80 |
| Phosphorus (P) | 1.40 | 0.18 | 0.45 |
Composition and nutrient levels of diets (dry matter basis) (Unit: %).
| Items | Days 1 to 50 | Days 51 to 100 | ||
|---|---|---|---|---|
| Control Group | Test Group | Control Group | Test Group | |
| Ingredients | ||||
| Milk replacer | 51.21 | 51.21 | 37.63 | 37.63 |
| Alfalfa hay | 48.79 | 32.53 | 62.37 | 31.185 |
| Supplemental concentrate | - | 16.26 | - | 31.185 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Nutrient levels | ||||
| Crude protein (CP) | 19.54 | 20.76 | 17.67 | 20.01 |
| Ether extract (EE) | 14.73 | 15.34 | 11.06 | 12.25 |
| Neutral detergent fiber (NDF) | 27.54 | 20.14 | 35.21 | 21.00 |
| Acid detergent fiber (ADF) | 19.71 | 13.81 | 25.20 | 13.88 |
| Calcium (Ca) | 1.76 | 1.73 | 1.55 | 1.50 |
| Phosphorus (P) | 0.80 | 0.85 | 0.64 | 0.72 |
Effect of concentrate supplementation on growth performance of yak calves.
| Items | Control Group | Test Group | |
|---|---|---|---|
| Dry matter intake (g) | 1 336.37 ± 94.85 b | 1 469.97 ± 6.24 a | 0.003 |
| Body weight (kg) | 69.30 ± 1.16 b | 76.13 ± 1.80 a | 0.005 |
| Average daily gain (g) | 426.68 ± 8.89 | 449.23 ± 10.65 | 0.121 |
a,b within a row with different superscripts means significantly difference. Different letters on the shoulder of the same row of data indicate significant differences (p < 0.05), and no letters or the same letters indicate non-significant differences (p > 0.05). The same as the table below.
Effect of concentrate supplementation on nutrient apparent digestibility of yak calves (Unit: %).
| Items | Control Group | Test Group | |
|---|---|---|---|
| CP | 78.39 ± 0.82 b | 82.50 ± 1.38 a | 0.028 |
| EE | 89.83 ± 0.57 b | 92.30 ± 0.91 a | 0.044 |
| NDF | 81.90 ± 1.04 b | 73.79 ± 3.41 a | 0.046 |
| ADF | 73.63 ± 1.27 b | 69.79 ± 0.36 a | 0.016 |
| Ca | 62.76 ± 2.91 b | 75.26 ± 1.29 a | <0.001 |
| P | 26.86 ± 1.73 b | 29.74 ± 2.63 a | <0.001 |
a,b within a row with different superscripts means significantly difference. Different letters on the shoulder of the same row of data indicate significant differences (p < 0.05), and no letters or the same letters indicate non-significant differences (p > 0.05). The same as the table below.
Effect of concentrate supplementation on pancreatic organ index of yak calves.
| Items | Control Group | Test Group | |
|---|---|---|---|
| Pancreas weight (g) | 67.86 ± 1.62 b | 86.58 ± 2.48 a | 0.048 |
| Organ index (%) | 0.10 ± 0.03 b | 0.11 ± 0.02 a | 0.004 |
a,b within a row with different superscripts means significantly difference. Different letters on the shoulder of the same row of data indicate significant differences (p < 0.05), and no letters or the same letters indicate non-significant differences (p > 0.05). The same as the table below.
Figure 1(A) Internal morphological structure of pancreatic tissue under 10× microscope; (B) Internal morphological structure of pancreatic tissue under 20× microscope.
Figure 2(A–E) Effect of no supplementation of concentrate on morphological development of pancreatic tissue in yak calves under 10× microscope; (F–J) Effect of concentrate supplementation on morphological development of pancreatic tissue in yak calves under 10× microscope.
Effect of concentrate supplementation on the area of internal and external secretion of pancreas in yak calves (Unit: %).
| Items | Control Group | Test Group | |
|---|---|---|---|
| Total pancreatic exocrine part area share | 0.8275 ± 0.0272 b | 0.9039 ± 0.0197 a | 0.029 |
| Total pancreatic endocrine part area share | 0.0307 ± 0.0024 b | 0.0390 ± 0.0032 a | 0.044 |
| Area share of pancreatic endocrine to exocrine part | 0.0384 ± 0.0012 b | 0.0353 ± 0.0007 a | 0.030 |
a,b within a row with different superscripts means significantly difference. Different letters on the shoulder of the same row of data indicate significant differences (p < 0.05), and no letters or the same letters indicate non-significant differences (p > 0.05). The same as the table below.
Effect of Supplemental Concentrate on Main Digestive Enzyme Activities in Pancreas of Yak Calves (Unit: IU/L).
| Items | Control Group | Test Group | |
|---|---|---|---|
| Pancreatic amylase | 41.746 ± 0.127 b | 45.434 ± 0.249 a | 0.039 |
| Pancreatic lipase | 140.407 ± 4.020 b | 155.161 ± 3.464 a | 0.009 |
| Pancreatic protease | 175.410 ± 1.844 b | 196.966 ± 2.888 a | 0.005 |
| Chymotrypsin | 195.910 ± 6.583 b | 224.350 ± 5.938 a | 0.002 |
a,b within a row with different superscripts means significantly difference. Different letters on the shoulder of the same row of data indicate significant differences (p < 0.05), and no letters or the same letters indicate non-significant differences (p > 0.05). The same as the table below.
Effect of concentrate supplementation on pancreatic hormone content in yak calves (Unit: Ug/L).
| Items | Control Group | Test Group | |
|---|---|---|---|
| Glucagon | 0.281 ± 0.004 b | 0.312 ± 0.002 a | 0.042 |
| Insulin | 1.044 ± 0.034 b | 1.135 ± 0.011 a | 0.012 |
| Glucagon | 2.744 ± 0.040 b | 3.087 ± 0.050 a | 0.041 |
| Growth inhibitors | 0.293 ± 0.003 | 0.299 ± 0.002 | 0.587 |
a,b within a row with different superscripts means significantly difference. Different letters on the shoulder of the same row of data indicate significant differences (p < 0.05), and no letters or the same letters indicate non-significant differences (p > 0.05).
Differential metabolites in positive ion mode.
| Items | FC | VIP | Trend | |
|---|---|---|---|---|
| Dopaquinone | 0.2790 | 2.4151 | 0.0022 | ↓ 1 |
| 2-acetamido-3-(4-methoxyphenyl)propanoic acid | 2.4534 | 1.9560 | 0.0033 | ↑ |
| D-(+)-Proline | 2.0918 | 1.9263 | 0.0070 | ↑ |
| Hypoxanthine | 1.8473 | 1.6555 | 0.0074 | ↑ |
| ACar 2 (7:0) | 2.1751 | 1.3468 | 0.0077 | ↑ |
| O-Acetyl-L-carnitine | 2.3309 | 2.0457 | 0.0088 | ↑ |
| Ellagic acid | 1.7811 | 1.8492 | 0.0089 | ↑ |
| ACar (22:5) | 2.9093 | 1.4077 | 0.0097 | ↑ |
| Adipamide | 1.7423 | 1.7909 | 0.0105 | ↑ |
| Acetylcysteine | 1.9873 | 1.7905 | 0.0107 | ↑ |
| Phenylpyruvic acid | 0.5255 | 1.2840 | 0.0112 | ↓ |
| Corey Lactone Diol | 1.7025 | 1.0985 | 0.0115 | ↑ |
| UDP 3 | 2.0778 | 1.3672 | 0.0116 | ↑ |
| PC 4 (20:5e/4:0) | 0.1133 | 2.4254 | 0.0117 | ↓ |
| Gamma-Glutamylcysteine | 2.1049 | 1.3942 | 0.0130 | ↑ |
| Prostaglandin A3 | 1.5521 | 1.3625 | 0.0159 | ↑ |
| Uric acid | 1.3932 | 1.0666 | 0.0177 | ↑ |
| 2-oxa-4-azatetracyclo [6.3.1.1~6,10~.0~1,5~] tridecan-3-one | 1.8355 | 1.3543 | 0.0182 | ↑ |
| Creatinine | 1.6563 | 1.3009 | 0.0200 | ↑ |
| Tetrahydrocorticosterone | 2.6623 | 1.1505 | 0.0262 | ↑ |
| Thiazolidine-4-carboxylic acid | 2.0473 | 1.2061 | 0.0266 | ↑ |
| LSD 5-d3 | 1.8016 | 1.7897 | 0.0270 | ↑ |
| PE 6 (18:5e/6:0) | 0.1866 | 2.1564 | 0.0274 | ↓ |
| Pyridoxamine | 1.8983 | 1.5306 | 0.0281 | ↑ |
| Nicotinamide | 1.5085 | 1.1741 | 0.0281 | ↑ |
| PE (18:1/20:5) | 0.6259 | 1.9053 | 0.0284 | ↓ |
| 23-Nordeoxycholic acid | 1.7533 | 1.1172 | 0.0285 | ↑ |
| MJN110 7 | 2.0824 | 1.4017 | 0.0310 | ↑ |
| Xanthine | 1.5591 | 1.1207 | 0.0329 | ↑ |
| 5-oxoproline | 1.5393 | 1.1173 | 0.0337 | ↑ |
| 2-Phenylacetamide | 1.7269 | 1.1676 | 0.0340 | ↑ |
| Tropolone | 1.7080 | 1.0937 | 0.0341 | ↑ |
| D-Serine | 1.6387 | 1.1970 | 0.0347 | ↑ |
| Pipecolic acid | 1.6846 | 1.2970 | 0.0347 | ↑ |
| PC (17:2/18:5) | 1.9933 | 1.4874 | 0.0364 | ↑ |
| PC (18:4e/6:0) | 0.1144 | 2.2393 | 0.0382 | ↓ |
| Gamma-Glutamylleucine | 1.8133 | 1.1139 | 0.0384 | ↑ |
| O-Phosphocolamine | 1.4013 | 1.1532 | 0.0384 | ↑ |
| N2-tetrahydrofuran-2-ylmethyl-4-(4-fluorophenyl)-1,3-thiazol-2-amine | 2.4647 | 1.2867 | 0.0386 | ↑ |
| ACar (18:2) | 2.4467 | 1.1459 | 0.0388 | ↑ |
| Uracil 1-beta-D-arabinofuranoside | 1.7342 | 1.7156 | 0.0393 | ↑ |
| Asparagine | 1.5276 | 1.0634 | 0.0397 | ↑ |
| PC (17:0/17:1) | 0.6580 | 1.5837 | 0.0405 | ↓ |
| DL-Tryptophan | 1.6126 | 1.1470 | 0.0417 | ↑ |
| Indole-3-acrylic acid | 1.6111 | 1.1445 | 0.0422 | ↑ |
| Ribulose-5-phosphate | 1.7376 | 1.1642 | 0.0440 | ↑ |
| Temazepam | 1.7146 | 1.3424 | 0.0441 | ↑ |
| 5'-S-Methyl-5'-thioadenosine | 1.7697 | 1.2447 | 0.0443 | ↑ |
| (+/-)5(6)-EET 8 | 1.8939 | 1.3987 | 0.0445 | ↑ |
| 2-Hydroxycinnamic acid | 1.6544 | 1.1037 | 0.0453 | ↑ |
| L-Phenylalanine | 1.5400 | 1.1056 | 0.0454 | ↑ |
| 6-Methylquinoline | 1.5664 | 1.0629 | 0.0461 | ↑ |
| Thymine | 1.7435 | 1.0853 | 0.0484 | ↑ |
| Trehalose | 1.6726 | 1.2917 | 0.0493 | ↑ |
| PC (16:0e/4:0) | 0.6476 | 1.2950 | 0.0494 | ↓ |
1 ↑ represents upward adjustment; ↓ represents downward adjustment. 2 ACar represents acylcarnitine. 3 UDP represents uridine diphosphate. 4 PC represents phosphatidycholine. 5 LSD represents lysergic acid diethylamide. 6 PE represents phosphatidylethanolamine. 7 MJN110 represents monoacylglycerol lipase inhibitor. 8 EET represents epoxyeicosatrienoic acid. The same as the table below.
Differential metabolites in negative ion mode.
| Items | FC | VIP | Trend | |
|---|---|---|---|---|
| LPE 1 (20:5) | 2.8219 | 2.4732 | 0.0008 | ↑ |
| Gamma-Glutamylcysteine | 2.9828 | 1.5129 | 0.0074 | ↑ |
| Docosapentaenoic acid | 2.0154 | 2.0502 | 0.0119 | ↑ |
| PC (16:1e/18:2) | 2.8861 | 2.0992 | 0.0140 | ↑ |
| LPG 2 (22:5) | 2.8985 | 1.4841 | 0.0149 | ↑ |
| FAHFA 3 (18:1/20:3) | 1.6771 | 1.9790 | 0.0242 | ↑ |
| PC (14:0/18:2) | 3.5938 | 1.0535 | 0.0274 | ↑ |
| PE (18:3e/18:2) | 2.8885 | 1.2124 | 0.0291 | ↑ |
| PE (18:2/18:3) | 2.5257 | 1.1019 | 0.0296 | ↑ |
| FAHFA (18:2/20:4) | 1.4077 | 1.2318 | 0.0307 | ↑ |
| LPG (22:4) | 2.8138 | 1.5457 | 0.0320 | ↑ |
| OxPC 4 (18:1-18:2+2O) | 3.1536 | 1.1076 | 0.0352 | ↑ |
| Octanedioic acid | 1.3331 | 1.2553 | 0.0357 | ↑ |
| 2.5356 | 1.1978 | 0.0370 | ↑ | |
| 1.8382 | 1.7902 | 0.0411 | ↑ | |
| Adrenic acid | 1.9676 | 1.2603 | 0.0414 | ↑ |
| 3-(methylsulfanyl)-5H-[1,2,4]triazino [5,6-b]indole | 0.2923 | 3.2189 | 0.0429 | ↓ |
| Docosahexaenoic acid | 1.4759 | 1.5493 | 0.0474 | ↑ |
| Xanthosine | 2.2922 | 1.0191 | 0.0491 | ↑ |
| LPS 5 (22:4) | 2.2800 | 2.2501 | 0.0493 | ↑ |
1 LPE represents lyso-phosphatidylethanolamine. 2 LPG represents lyso-phosphatidylglycerol. 3 FAHFA represents fatty acid esters of hydroxy fatty acids. 4 OxPC represents oxidized Phosphatidylcholines. 5 LPS represents lyso-phosphatidylserine.